Aramark (NYSE: ARMK) CEO receives 51,241 RSUs and 182,983 options

Rhea-AI Filing Summary

Aramark reported an equity award to its Chief Executive Officer and director on 12/01/2025. The CEO acquired 51,241 shares of common stock at a reference price of $37.08, increasing his directly held stake to 1,022,730.053 shares.

He also received stock options for 182,983 shares with a $37.08 exercise price, expiring on 12/01/2035. Both the restricted stock units and these options vest in four equal annual installments starting on the first anniversary of the grant date, tying a portion of his compensation to Aramark’s long-term share performance.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ZILLMER JOHN J

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/01/2025		A		51,241(1)	A	$37.08	1,022,730.053	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$37.08	12/01/2025		A		182,983		(2)	12/01/2035	Common Stock	182,983	$0	182,983	D

Explanation of Responses:

1. Represents restricted stock units, which vest in four equal annual installments beginning on the first anniversary of the date of grant.

2. These options to purchase shares of common stock vest in four equal annual installments beginning on the first anniversary of the date of grant.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	12/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Aramark (ARMK) report for its CEO?

Aramark reported that its Chief Executive Officer acquired 51,241 shares of common stock and received stock options for 182,983 shares on 12/01/2025.

At what price were the new Aramark (ARMK) equity awards granted to the CEO?

The CEO’s transaction shows a common stock price and stock option exercise price of $37.08 per share for the 12/01/2025 grants.

How many Aramark (ARMK) shares does the CEO hold after this transaction?

Following the reported transaction, the CEO beneficially owns 1,022,730.053 shares of Aramark common stock in direct ownership.

How do the new Aramark (ARMK) restricted stock units vest?

The 51,241 restricted stock units vest in four equal annual installments, beginning on the first anniversary of the 12/01/2025 grant date.

What are the terms of the new Aramark (ARMK) stock options granted to the CEO?

The CEO received 182,983 stock options with a $37.08 exercise price, expiring on 12/01/2035, vesting in four equal annual installments starting one year after grant.

Is the Aramark (ARMK) CEO both an officer and a director?

Yes. The reporting person is identified as both a Director and an Officer, serving as Chief Executive Officer of Aramark.